Across TCGA pan-cancer cohorts, H2BW3P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated H2BW3P data layer compared with 22 for mass-spec protein.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher H2BW3P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated H2BW3P expression acts as an unfavorable survival marker.
STAD are the cancer types where H2BW3P Mutation most reproducibly stratifies survival.